Back to search
Neoplasm of Breast (Disorder)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Neoplasm of Breast (Disorder) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Neoplasm of Breast (Disorder) trials you may qualify forThe goal of this clinical trial is to test the effect of an affect-based exercise prescription on moderate-vigorous physical activity participation among surviv…
Background: A person s tumor is studied for mutations. When cells are found that can attack the mutation in a person s tumor, the genes from those cells are st…
This clinical trial is looking at UCB4594. This is the first time the drug is being tested in humans. UCB4594 is a type of drug called a monoclonal antibody. It…
The purpose of this study is to evaluate the efficacy and safety of SKB264 in patients with unresectable locally advanced, recurrent, or metastatic HR+/HER2- br…
This is a Phase II randomized, controlled, open label breast cancer clinical trial. 66 patients will be enrolled. The drugs being studied are hydroxychloroquine…
The goal of this observational study is to learn if a new diagnostic test using specific labels for breast cancer sEVs on a microchip can accurately diagnose th…
This phase III trial compares the effect of low dose tamoxifen to usual hormonal therapy, including aromatase inhibitors, in treating post-menopausal women with…
Breast cancer (BCa) is the most common cancer in women. The majority of BCa are hormone receptor positive and substantial benefits have been demonstrated for ad…